NTRK1 and glioblastoma: The ability of foretinib to inhibit the TAM family members of receptor tyrosine kinases (Tyro3, Axl, and MerTK) hindered the survival, proliferation, and migration of glioblastoma cell lines in vitro and reduced glioblastoma tumor growth in a subcutaneous mouse model [29].